scholarly journals Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice

2011 ◽  
Vol 6 (6) ◽  
pp. 748-753 ◽  
Author(s):  
Clare Appleby ◽  
Raj Khattar ◽  
Kenneth Morgan ◽  
Bernard Clarke ◽  
Nicholas Curzen ◽  
...  
Keyword(s):  
Real World ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes

2015 ◽  
Vol 87 (2) ◽  
pp. 200-208 ◽  
Author(s):  
Alexandre Benjo ◽  
Rhanderson N. Cardoso ◽  
Tyrone Collins ◽  
Daniel Garcia ◽  
Francisco Y. Macedo ◽  
...  
Keyword(s):  
Meta Analysis ◽  
Drug Eluting Stents ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Vascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

Treatment of In-stent Restenosis – Past, Present and Future

2009 ◽  
Vol 5 (2) ◽  
pp. 74 ◽  
Author(s):  
Fernando Alfonso ◽  
Keyword(s):  
Clinical Problem ◽  
Historical Background ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Future Perspectives ◽  
Technical Challenge ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

In-stent restenosis (ISR) remains a significant clinical problem. The penetration of drug-eluting stents (DES) is quite variable and patients with DES may also suffer from ISR. Treatment of ISR remains a technical challenge and the long-term clinical outcome of these patients may be complicated by recurrences. Different strategies have been used for the treatment of patients with bare-metal ISR. Currently, DES constitute the intervention of choice in this setting. However, the best intervention for patients suffering from ISR after DES implantation remains to be elucidated. This report summarises our clinical and research efforts in this adverse anatomical scenario over the last decade. We will address the treatment of patients with ISR, revisiting the historical background, emphasising the currently available alternatives and disclosing future perspectives.

scholarly journals TCT-661 Vascular Brachytherapy versus Drug-Eluting Stents in the Treatment of In-Stent Restenosis: a Meta-Analysis of Long Term Outcomes

2014 ◽  
Vol 64 (11) ◽  
pp. B192-B193
Author(s):  
Rhanderson N. Cardoso ◽  
Alexandre M. Benjo ◽  
Tyrone Collins ◽  
Daniel Garcia ◽  
Francisco Y. Macedo ◽  
...  
Keyword(s):  
Meta Analysis ◽  
Drug Eluting Stents ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Vascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

scholarly journals In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

2019 ◽  
Vol 71 (1) ◽  
Author(s):  
Ganesh Paramasivam ◽  
Tom Devasia ◽  
Shabeer Ubaid ◽  
Ashwitha Shetty ◽  
Krishnananda Nayak ◽  
...  
Keyword(s):  
Real World ◽  
Clinical Presentation ◽  
Drug Eluting Stents ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dellʼEmilia-Romagna registry

2011 ◽  
Vol 12 (2) ◽  
pp. 102-109 ◽  
Author(s):  
Antonio Manari ◽  
Paolo Ortolani ◽  
Paolo Guastaroba ◽  
Paolo Marzaroli ◽  
Mila Menozzi ◽  
...  
Keyword(s):  
Drug Eluting Stents ◽  
Bare Metal ◽  
Cobalt Chromium ◽  
Long Term Outcomes ◽  
Drug Eluting

Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis

2018 ◽  
Vol 26 (6) ◽  
pp. 277-286 ◽  
Author(s):  
Sahil Khera ◽  
Pedro A. Villablanca ◽  
Dhaval Kolte ◽  
Tanush Gupta ◽  
Mohammed Hasan Khan ◽  
...  
Keyword(s):  
End Stage Renal Disease ◽  
Bare Metal Stents ◽  
Drug Eluting Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Long Term Outcomes ◽  
Drug Eluting ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document